New data from Aichi Medical University, Department of Urology illuminate research in bladder cancer therapy

Researchers detail in "Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer," new data in bladder cancer. "Expression of human epidermal growth factor receptor-2 (HER-2/neu or HER-2) oncoprotein in invasive bladder cancer was examined by immunohistochemical staining in order to evaluate the potential for molecular-targeted therapy targeting HER-2 as a tailor-made treatment for patients with invasive bladder cancer. This study included 40 patients who were examined at Aichi Medical University Hospital and were pathologically diagnosed with invasive transitional cell carcinoma of the bladder (pT2 to pT4)," scientists writing...

Want to see the full article?

• Purchase this article for only $3.00